Etoricoxib API Powder

Etoricoxib is a selective COX-2 inhibitor Active Pharmaceutical Ingredient (API) widely used in the manufacture of anti-inflammatory and analgesic formulations. It is commonly prescribed for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gout, and other painful inflammatory conditions. Product Details Product Name: Etoricoxib API CAS Number: 202409-33-4 Molecular Formula: C₁₈H₁₅ClN₂O₂S Molecular Weight: 358.84 g/mol Appearance: White to Off-White Crystalline Powder Category: Anti-inflammatory / NSAID API Therapeutic Class: Selective COX-2 Inhibitor Purity: Typically ≥99.0% (HPLC) Grade: IP / BP / USP Storage: Store in a cool, dry place away from moisture and direct sunlight. Applications Osteoarthritis formulations Rheumatoid arthritis medications Ankylosing spondylitis treatment Acute gout management Post-operative pain relief Musculoskeletal pain formulations Key Features Highly selective COX-2 inhibition Effective pain and inflammation management Lower gastrointestinal side effects compared to traditional NSAIDs Suitable for tablet and capsule formulations Consistent impurity profile and excellent stability Available with COA, MSDS, and regulatory documentation support Packaging 1 Kg, 5 Kg, 25 Kg HDPE/Fiber Drums Double polyethylene liner packing available Customized export packaging on request About the Company GST Registration Date: 2025 Legal Status of Firm: Proprietorship Number of Employees: Upto 10 People Annual Turnover: 0 - 40 L